证券记录 · 已归档季度
VNDA
Vanda Pharmaceuticals Inc. · Healthcare · Biotechnology
17被追踪持有人
0Δ持有人
25.97M持有股份
$129.59M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +0.5% · 净新建仓位 -5.9% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | 0 | 37.76M | $231.07M | +7 | −7 |
| Q1 2026 | 78 | +6 | 33.85M | $233.91M | +14 | −8 |
| Q4 2025 | 72 | -1 | 30.64M | $270.14M | +1 | −2 |
| Q3 2025 | 17 | 0 | 25.97M | $129.59M | — | −1 |
| Q2 2025 | 15 | 0 | 24.58M | $116.00M | — | — |
| Q1 2025 | 12 | 0 | 9.69M | $44.48M | — | — |
| Q4 2024 | 12 | +1 | 8.66M | $41.48M | +1 | — |
| Q3 2024 | 10 | -1 | 7.15M | $33.54M | — | −1 |
| Q2 2024 | 11 | — | 6.99M | $39.47M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 3.59M | +0.4% | $17.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 3.59M | +0.4% | $17.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 3.59M | +0.4% | $17.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (被动) | 3.59M | +0.4% | $17.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 3.48M | +0.8% | $17.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Millennium Management ✦ | 3.25M | +4.2% | $16.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 1.39M | -17.7% | $6.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 1.39M | -17.7% | $6.95M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (被动) | 1.27M | +0.4% | $6.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 668.47K | +392.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 668.47K | +392.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 668.47K | +392.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 668.47K | +392.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 662.30K | +25.7% | $3.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 637.50K | — | $3.18M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 581.25K | +23.2% | $2.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | Marshall Wace ✦ | 581.25K | +23.2% | $2.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | Marshall Wace ✦ | 581.25K | +23.2% | $2.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 399.79K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Goldman Sachs Group ✦ | 339.70K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Goldman Sachs Group ✦ | 339.70K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Citadel Advisors ✦ | 263.81K | +78.5% | $1.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Citadel Advisors ✦ | 263.81K | +78.5% | $1.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | Wellington Management ✦ | 189.05K | -35.4% | $943,345 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Wellington Management ✦ | 189.05K | -35.4% | $943,345 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 51 | Wellington Management ✦ | 189.05K | -35.4% | $943,345 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 52 | Fidelity (FMR) ✦ | 179.54K | +11.1% | $895,908 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 53 | Fidelity (FMR) ✦ | 179.54K | +11.1% | $895,908 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 54 | D. E. Shaw & Co. ✦ | 122.33K | -25.5% | $610,412 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 55 | D. E. Shaw & Co. ✦ | 122.33K | -25.5% | $610,412 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 56 | T. Rowe Price ✦ | 29.26K | +9.3% | $146,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $542,800 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 168 持有人, 45.91M 股份, $293.46M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据